[HTML][HTML] Actionable diagnosis of neuroleptospirosis by next-generation sequencing

MR Wilson, SN Naccache, E Samayoa… - … England Journal of …, 2014 - Mass Medical Soc
MR Wilson, SN Naccache, E Samayoa, M Biagtan, H Bashir, G Yu, SM Salamat…
New England Journal of Medicine, 2014Mass Medical Soc
A 14-year-old boy with severe combined immunodeficiency presented three times to a
medical facility over a period of 4 months with fever and headache that progressed to
hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic
workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of
the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding
to leptospira infection. Clinical assays for leptospirosis were negative. Targeted …
A 14-year-old boy with severe combined immunodeficiency presented three times to a medical facility over a period of 4 months with fever and headache that progressed to hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding to leptospira infection. Clinical assays for leptospirosis were negative. Targeted antimicrobial agents were administered, and the patient was discharged home 32 days later with a status close to his premorbid condition. Polymerase-chain-reaction (PCR) and serologic testing at the Centers for Disease Control and Prevention (CDC) subsequently confirmed evidence of Leptospira santarosai infection.
The New England Journal Of Medicine